Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (321-330 of 383) with videos related to

Pageof 39
Sort By:
Breast (Edinburgh, Scotland)|October 18, 2025
The role of body mass index at diagnosis in patients with inflammatory breast cancerKristien Borremans, Ha-Linh Nguyen, Maxim De Schepper, et al.
Cancer Research Communications|December 26, 2023
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic TherapyMaxim De Schepper, Ha-Linh Nguyen, François Richard, et al.
EMBO Molecular Medicine|October 5, 2013
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formationRossella Lucá, Michele Averna, Francesca Zalfa, et al.
Clinical Chemistry|June 30, 2022
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing DatasetsHuiwen Che, Tatjana Jatsenko, Liesbeth Lenaerts, et al.
Nature Communications|December 25, 2025
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissueKristien Borremans, Anirudh Pabba, Gitte Zels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function TrialKarin Ribi, Weixiu Luo, Jürg Bernhard, et al.
British Journal of Cancer|January 18, 2020
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trialKarin Ribi, Weixiu Luo, Marco Colleoni, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2023
Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancerKaren Van Baelen, Ha-Linh Nguyen, Anne-Sophie Hamy-Petit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2020
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)Stephen R D Johnston, Nadia Harbeck, Roberto Hegg, et al.
BMJ Open|August 22, 2025
Study protocol for a pragmatic randomised controlled trial in Belgian primary care and hospital settings on the effectiveness of an eHealth self-management support programme consisting of pain education and coaching of activity needs in breast cancer survivors with persistent pain: the PECAN trialAn De Groef, Lore Dams, G Lorimer Moseley, et al.
Pageof 39

Showing results (321-330 of 383) with videos related to

Sort By:
Pageof 39
Breast (Edinburgh, Scotland)|October 18, 2025
The role of body mass index at diagnosis in patients with inflammatory breast cancerKristien Borremans, Ha-Linh Nguyen, Maxim De Schepper, et al.
Cancer Research Communications|December 26, 2023
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic TherapyMaxim De Schepper, Ha-Linh Nguyen, François Richard, et al.
EMBO Molecular Medicine|October 5, 2013
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formationRossella Lucá, Michele Averna, Francesca Zalfa, et al.
Clinical Chemistry|June 30, 2022
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing DatasetsHuiwen Che, Tatjana Jatsenko, Liesbeth Lenaerts, et al.
Nature Communications|December 25, 2025
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissueKristien Borremans, Anirudh Pabba, Gitte Zels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function TrialKarin Ribi, Weixiu Luo, Jürg Bernhard, et al.
British Journal of Cancer|January 18, 2020
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trialKarin Ribi, Weixiu Luo, Marco Colleoni, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2023
Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancerKaren Van Baelen, Ha-Linh Nguyen, Anne-Sophie Hamy-Petit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2020
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)Stephen R D Johnston, Nadia Harbeck, Roberto Hegg, et al.
BMJ Open|August 22, 2025
Study protocol for a pragmatic randomised controlled trial in Belgian primary care and hospital settings on the effectiveness of an eHealth self-management support programme consisting of pain education and coaching of activity needs in breast cancer survivors with persistent pain: the PECAN trialAn De Groef, Lore Dams, G Lorimer Moseley, et al.
Pageof 39